Other drugs in development Other multiagonists based on GLP-1 in combination with peptides such as GIP, GCG, PYY, secretin, and GLP-2as well as new triagonists and tetraagonists incorporating DACRA agonismare currently in the early stages of development1,59 (Table 2)
MOTS-C improves glucose metabolism and insulin sensitivity, supporting healthy blood sugar regulation, metabolic flexibility, and reducing risk factors for metabolic syndrome and type 2 diabetes
In an animal study, using a mouse model with different age groups, non-alcoholic steatohepatitis (NASH) was induced, revealing age-dependent effects on cardiac function
This engagement extends beyond sexual signaling and interacts with broader appetite and reward biology pathways